Condition: Prostate Disease · Prostate CA · Sponsor: Uro-1 Medical
Currently used biopsy devices do not predictably obtain full cores of tissue and the tissue obtained is often fragmented and disrupted making it difficult for pathological review. This post-market study will assess the utility of the SUREcore biopsy needle and the coreCARE specimen retrieval device versus a standard of care biopsy needle and the typical tissue container used in urology offices and clinics today.
This description comes directly from the study's public registry record.
Thomas Lawson, PhD · 5102061794 · drthomlawson@gmail.com
Jack Snoke · 3365750434 · pjsnoke@uro1medical.com
Always discuss trial participation with your own doctor first.
| Georgia Urology | Cartersville, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05470127